Freeman MJ - Search Results

1

A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease.

Crawford FC, Freeman MJ, Schinka JA, Abdullah LI, Gold M, Hartman R, Krivian K, Morris MD, Richards D, Duara R, Anand R, Mullan MJ. Crawford FC, et al. Among authors: freeman mj. Neurology. 2000 Sep 26;55(6):763-8. doi: 10.1212/wnl.55.6.763. Neurology. 2000. PMID: 10993992

2

The genetic association between Cathepsin D and Alzheimer's disease.

Crawford FC, Freeman MJ, Schinka J, Abdullah LI, Richards D, Sevush S, Duara R, Mullan MJ. Crawford FC, et al. Among authors: freeman mj. Neurosci Lett. 2000 Jul 28;289(1):61-5. doi: 10.1016/s0304-3940(00)01260-x. Neurosci Lett. 2000. PMID: 10899409 Clinical Trial.

3

Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene.

Crawford FC, Freeman MJ, Schinka JA, Morris MD, Abdullah LI, Richards D, Sevush S, Duara R, Mullan MJ. Crawford FC, et al. Among authors: freeman mj. Exp Neurol. 2001 Feb;167(2):456-9. doi: 10.1006/exnr.2000.7560. Exp Neurol. 2001. PMID: 11161635

4

APOE genotype influences acquisition and recall following traumatic brain injury.

Crawford FC, Vanderploeg RD, Freeman MJ, Singh S, Waisman M, Michaels L, Abdullah L, Warden D, Lipsky R, Salazar A, Mullan MJ. Crawford FC, et al. Among authors: freeman mj. Neurology. 2002 Apr 9;58(7):1115-8. doi: 10.1212/wnl.58.7.1115. Neurology. 2002. PMID: 11940706

5

The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample.

Crawford F, Town T, Freeman M, Schinka J, Gold M, Duara R, Mullan M. Crawford F, et al. Neurosci Lett. 1999 Aug 6;270(3):133-6. doi: 10.1016/s0304-3940(99)00470-x. Neurosci Lett. 1999. PMID: 10462112

6

No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples.

Crawford F, Freeman M, Town T, Fallin D, Gold M, Duara R, Mullan M. Crawford F, et al. Neurosci Lett. 1999 May 14;266(3):193-6. doi: 10.1016/s0304-3940(99)00303-1. Neurosci Lett. 1999. PMID: 10465706

7

No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States.

Crawford F, Freeman M, Abdullah L, Schinka J, Gold M, Duara R, Mullan M. Crawford F, et al. Ann Neurol. 2000 May;47(5):687. Ann Neurol. 2000. PMID: 10805350 No abstract available.

8

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

Wilcock DM, Rojiani A, Rosenthal A, Levkowitz G, Subbarao S, Alamed J, Wilson D, Wilson N, Freeman MJ, Gordon MN, Morgan D. Wilcock DM, et al. Among authors: freeman mj. J Neurosci. 2004 Jul 7;24(27):6144-51. doi: 10.1523/JNEUROSCI.1090-04.2004. J Neurosci. 2004. PMID: 15240806 Free PMC article.

9

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage.

Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, Morgan D. Wilcock DM, et al. Among authors: freeman mj. J Neuroinflammation. 2004 Dec 8;1(1):24. doi: 10.1186/1742-2094-1-24. J Neuroinflammation. 2004. PMID: 15588287 Free PMC article.

10

Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice.

Herber DL, Mercer M, Roth LM, Symmonds K, Maloney J, Wilson N, Freeman MJ, Morgan D, Gordon MN. Herber DL, et al. Among authors: freeman mj. J Neuroimmune Pharmacol. 2007 Jun;2(2):222-31. doi: 10.1007/s11481-007-9069-z. Epub 2007 Mar 27. J Neuroimmune Pharmacol. 2007. PMID: 18040847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters